Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07568444 · ClinicalTrials.gov registry record · Phase 2

Enhancing Readability of Lay Abstracts and Summaries for Medical Knowledge Using Generative Artificial Intelligence (BRIDGE AI 3)

A Phase 2 study, sponsored by University of Southern California.

Completed
Registry status
Phase 2
Development phase
120
Enrollment target

NCT07568444 is a Phase 2 study that has completed, run by University of Southern California. The registered enrollment target is 120 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07568444, a Phase 2 study, has completed, sponsored by University of Southern California.

COMPLETED
Registry status
Phase 2
Development phase
120 participants
Enrollment target

Study Summary

This trial tests if AI can help make medical info clear and readable. Many patients struggle to find medical informations that easy to read and understand from verified medical sources. The study tests if an AI tool can assist health providers to craft clear text for patients more fast than what they do now. Health providers are split at random into two groups-one uses the AI tool and one does not. The trial tests how clear the text is, how correct it is, and how much time is saved. The aim is to see if AI can close the gap between complex research and what patients can grasp.

Interventions

  • OTHER Pub2Post

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2025-01-16
Est. Completion 2025-02-27
Phase Phase 2

Sponsor

University of Southern California

617 total trials

What the Registry Record Tells You About NCT07568444

The ClinicalTrials.gov registry entry for NCT07568444 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Pub2Post is the first listed.

NCT07568444 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07568444 about?

NCT07568444 is a clinical study titled "Enhancing Readability of Lay Abstracts and Summaries for Medical Knowledge Using Generative Artificial Intelligence (BRIDGE AI 3)". This trial tests if AI can help make medical info clear and readable. Many patients struggle to find medical informations that easy to read and understand from verified medical sources. The study tests if an AI tool can assist health providers to craft clear text for patients more fast than what the...

What is the current status of trial NCT07568444?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 2025-01-16. Estimated completion is 2025-02-27.

What interventions are being tested in trial NCT07568444?

The interventions under investigation include: Pub2Post (OTHER).

Who is sponsoring clinical trial NCT07568444?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.